39 results on '"Yong, Jie Ning"'
Search Results
2. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
3. Natural history of NASH cirrhosis in liver transplant waitlist registrants
4. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis
5. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies
6. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis
7. An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
8. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
9. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
10. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review
11. A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease
12. A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation
13. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
14. The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis.
15. Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US.
16. The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome.
17. Examining the interim proposal for name change to steatotic liver disease in the US population.
18. De novo metabolic syndrome after liver transplantation: a meta-analysis on cumulative incidence, risk factors, and outcomes.
19. Meta‐analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
20. Complete alcohol abstinence increases the risk of NAFLD but not severity. A population analysis with transient elastography.
21. A qualitative systematic review of anonymous/unspecified living kidney and liver donors' perspectives.
22. A network meta-analysis of 12,116 individuals from randomized controlled trials in the treatment of depression after acute coronary syndrome.
23. Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals.
24. Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives.
25. Placebo effect on progression and regression in NASH: Evidence from a meta‐analysis.
26. Meta‐analysis: analysis of mechanistic pathways in the treatment of non‐alcoholic steatohepatitis. Evidence from a Bayesian network meta‐analysis.
27. A Diagnostic Test Meta‐Analysis Evaluating Imaging‐Based and Blood Biomarker–Based Assessment Tools for Fibrosis After Liver Transplantation.
28. A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients.
29. Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis.
30. Endoscopic submucosal dissection versus endoscopic mucosal resection for rectal carcinoid tumor. A meta‐analysis and meta‐regression with single‐arm analysis.
31. Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis.
32. Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019.
33. Mo1575 ETHNIC DISPARITIES IN OUTCOMES OF NON-ALCOHOLIC STEATOHEPATITIS PATIENTS AWAITING LIVER TRANSPLANTATION IN THE UNITED STATES.
34. Sa1597 REDEFINING THE DIAGNOSTIC CRITERIA OF METABOLIC SYNDROME WITH THE INCLUSION OF NON-ALCOHOLIC FATTY LIVER DISEASE: A NATIONWIDE PROSPECTIVE COHORT STUDY.
35. Sa1543 PREVALENCE OF CLINICALLY SIGNIFICANT AND ADVANCED FIBROSIS IN INDIVIDUALS WITH ALPHA-1-ANTITRYPSIN DEFICIENCY: SYSTEMATIC REVIEW AND META-ANALYSIS.
36. Sa1542 OUTCOMES AND SURVIVAL OF ALPHA 1 ANTITRYPSIN DEFICIENCY IN LIVER TRANSPLANTATION.
37. 92: FOREGUT BYPASS VERSUS RESTRICTIVE BARIATRIC PROCEDURES FOR NONALCOHOLIC FATTY LIVER DISEASE. A META-ANALYSIS OF 1,823 INDIVIDUALS.
38. 91: COULD NON-ALCOHOLIC STEATOHEPATITIS SPONTANEOUSLY REGRESS? EVIDENCE FROM 2,649 INDIVIDUALS ON PLACEBO IN RANDOMIZED CONTROLLED TRIALS.
39. A NETWORK META-ANALYSIS OF 12,116 INDIVIDUALS FROM RANDOMIZED CONTROLLED TRIALS IN THE TREATMENT OF DEPRESSION AFTER ACUTE CORONARY SYNDROME.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.